wegovy glp-1 receptor agonist hydration effects 2025 GI Adverse of Glucagon-Like Peptide-1 Agonists Medscape | Just over half
Description
Advertisement SELECT was designed to determine whether semaglutide can exert protective cardiovascular effects in patients with overweight or obesity in the absence of diabetes
doi: 10.1016/j.xcrm.2021.100263 74 VniantMMLuSCAtanganLKomorowskiRStanislausSChengYet al
Diabetes Complications 39 , 109045 (2025)
Beiroa et al., 2014
The prescribing information also includes a boxed warning for thyroid C-cell tumors and several other important precautions
